Centessa Pharmaceuticals PLC (CNTA)
18.19
+1.45
(+8.66%)
USD |
NASDAQ |
Nov 21, 16:00
17.10
-1.09
(-5.99%)
Pre-Market: 09:07
Centessa Pharmaceuticals Total Assets (Quarterly): 609.72M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 609.72M |
| June 30, 2024 | 398.84M |
| March 31, 2024 | 328.17M |
| December 31, 2023 | 360.25M |
| September 30, 2023 | 377.36M |
| June 30, 2023 | 392.92M |
| March 31, 2023 | 403.86M |
| December 31, 2022 | 444.31M |
| Date | Value |
|---|---|
| September 30, 2022 | 479.36M |
| June 30, 2022 | 521.05M |
| March 31, 2022 | 582.19M |
| December 31, 2021 | 629.64M |
| September 30, 2021 | 612.21M |
| June 30, 2021 | 643.76M |
| March 31, 2021 | 320.52M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
320.52M
Minimum
Mar 2021
643.76M
Maximum
Jun 2021
473.61M
Average
444.31M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals PLC | 17.67M |
| Verona Pharma PLC | 381.82M |
| Autolus Therapeutics PLC | 827.49M |
| Mereo BioPharma Group PLC | 88.75M |
| Achilles Therapeutics PLC | 122.68M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 110.58M |
| Shareholders Equity (Quarterly) | 499.14M |